Study Stopped
Pending internal study review and potential protocol modification
dorsaVi Back Pain and Movement Registry
BPAM
1 other identifier
observational
350
1 country
3
Brief Summary
This study will compare patients with low back pain (LBP) to age and gender matched controls to determine if there are differences between the two groups related to: range of movement, secondary outcomes (level of disability, quality of life, evidence of depression, anxiety or stress), movement patterns and demographic characteristics. The first phase will include a baseline and 3 month follow-up assessment of the LBP patients and controls, including demographic characteristics, outcome measures, and a physical assessment. The second phase is an ongoing phase with continued interim assessments of LBP patients only, at 6 and 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 19, 2016
CompletedFirst Posted
Study publicly available on registry
December 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedFebruary 8, 2019
February 1, 2019
3.5 years
December 19, 2016
February 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Range of Movement from baseline
Maximal range of low back movement in sagittal and coronal planes
Baseline, 3 months, 6 months, and 12 months
Secondary Outcomes (9)
Change in Muscle Activity from baseline
Baseline, 3 months, 6 months, and 12 months
Change in Pain from baseline
Baseline, 3 months, 6 months, and 12 months
Change in Keele StarT Back Tool scores from baseline
Baseline, 3 months, 6 months, and 12 months
Change in Fear Avoidance Beliefs Questionnaire responses from baseline
Baseline, 3 months, 6 months, and 12 months
Change in Low Back Pain Classifier score from baseline
Baseline, 3 months, 6 months, and 12 months
- +4 more secondary outcomes
Study Arms (2)
Group A - Low Back Pain
Group A: * Subject provides written authorization and/or consent per institution and geographical requirements * Subjects in Group A with a predominant complaint of Low back pain, with a minimum daily average VAS ≥ 30/100 * Subjects in Group A are intended to be assessed with ViMove based on standard of care * Subject is willing to participate in follow-ups at 3, 6, 12 months post initial assessment Observational study, no intervention
Group B - Without Low Back Pain
* Subject is without current low back pain * Subject does not have a history of low back pain lasting longer than 3 months in the past 12 months * Subject is willing to follow up 3 months post initial assessment Observational study, no intervention
Eligibility Criteria
Group A: • Subject present with a predominant complaint of Low Back Pain, with a minimum daily average VAS ≥ 30/100 Group B: • Subject is without current low back pain
You may qualify if:
- Group A:
- Subject provides written authorization and/or consent per institution and geographical requirements
- Subjects in Group A with a predominant complaint of Low back pain, with a minimum daily average VAS ≥ 30/100
- Subjects in Group A are intended to be assessed with ViMove based on standard of care - Subject is willing to participate in follow ups at 3, 6, 12 months post initial assessment
- Group B:
- Subject is without current low back pain
- Subject does not have a history of low back pain lasting longer than 3 months in the past 12 months
- Subject is willing to follow up 3 months post initial assessment
You may not qualify if:
- Subject who is, or is expected to be inaccessible for follow-up
- Subject in whom movement assessment is contraindicated.
- Subject is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
- Body mass index ≥ 35 - In Group B only, subjects who had a history of low back pain in the past 12 months which lasted \> 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- dorsaVi Ltdlead
- International Spine, Pain and Performance Centercollaborator
Study Sites (3)
The George Washington University
Washington DC, Maryland, 20006, United States
International Spine, Pain and Performance Center
Washington DC, Maryland, 20037, United States
Synergy Manual Physical Therapy LLC
Arlington, Virginia, 22209, United States
Related Publications (1)
Desai MJ, Jonely H, Blackburn M, Wanasinghage S, Sheikh S, Taylor RS. The Back Pain and Movement (B-PAM) registry; a study protocol. BMC Musculoskelet Disord. 2019 May 24;20(1):249. doi: 10.1186/s12891-019-2625-x.
PMID: 31122221DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehul J Desai, MD
International Spine, Pain and Performance Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2016
First Posted
December 22, 2016
Study Start
October 1, 2016
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
February 8, 2019
Record last verified: 2019-02